Prelude Therapeutics Inc (PRLD)

Prelude Therapeutics Inc (PRLD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $258M; returns 1 day +0.8%, 1 week +11.3%, 1 year +142.0%.

Prelude Therapeutics Inc. is a clinical-stage precision oncology company headquartered in Wilmington, Delaware, focused on the discovery and development of novel small molecule therapies for genetically defined cancer targets.

Groups PRLD belongs to

• Clinical Stage Biotech
• Precision Medicine
• Biotechnology
• Oncology
• Healthcare
• Cancer Therapeutics
• Clinical Stage
• Drug Discovery
• Biopharmaceutical

PRLD financial model: income statement, cash flow and balance sheet